Circulating reticulated platelets over time in patients with myocardial infarction treated with prasugrel or ticagrelor

Journal of Thrombosis and Thrombolysis

Volumn 40, Issue 1, 2015, Pages 70-75

  Eisen, Alon ^a,b   Lerman Shivek, Hila ^c,d   Perl, Leor ^a,b   Rechavia, Eldad ^a,b   Leshem Lev, Dorit ^a   Zemer Wassercug, Noa ^a,b   Dadush, Oshrat ^a   Kazum, Shirit ^a,b   Codner, Pablo ^a,b   Kornowski, Ran ^a,b   Lev, Eli I ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c HASHARON HOSPITAL   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acute coronary syndrome; Antiplatelet therapy; Reticulated platelets

Indexed keywords

ACETYLSALICYLIC ACID; PRASUGREL; THIAZOLE ORANGE; TICAGRELOR; ADENOSINE; ANTITHROMBOCYTIC AGENT; PURINERGIC P2Y RECEPTOR ANTAGONIST;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CIRCULATING RETICULATED PLATELET; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FLOW CYTOMETER; FLOW CYTOMETRY; HUMAN; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; THROMBOCYTE; THROMBOCYTE FUNCTION ANALYZER; ANALOGS AND DERIVATIVES; BLOOD; BLOOD CLOTTING PARAMETERS; DRUG EFFECTS; METABOLISM; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSIOLOGY; PROCEDURES; THROMBOCYTE ACTIVATION; TIME FACTOR; TREATMENT OUTCOME;

ADENOSINE; AGED; BLOOD PLATELETS; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PRASUGREL HYDROCHLORIDE; PROSPECTIVE STUDIES; PURINERGIC P2Y RECEPTOR ANTAGONISTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84940670987     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-014-1156-4     Document Type: Article

References (22)

1. Campo G, Parrinello G, Ferraresi P et al (2011) Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome. J Am Coll Cardiol 57(25):2474–2483
2. Codner P, Vaduganathan M, Rechavia E et al (2012) Clopidogrel response up to six months after acute myocardial infarction. Am J Cardiol 110(3):321–325
3. Scalone G, Coviello I, Barone L et al (2011 Aug) Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction. Thromb Res 128(2):174–178
4. Price MJ, Angiolillo DJ, Teirstein PS et al (2011) Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: impact on thrombosis and safety (GRAVITAS) trial. Circulation 124:1132–1137
5. Mega JL, Close SL, Wiviott SD et al (2009) Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes. Circulation 119:2553–2560
6. Bonello L, Pansieri M, Mancini J et al (2011) High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes. J Am Coll Cardiol 58:467–473
7. Parodi G, Marcucci R, Valenti R et al (2011) High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI. JAMA 306:1215–1223
8. Aradi D, Komócsi A, Vorobcsuk A et al (2010 Sep) Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis. Am Heart J 160(3):543–551
9. Michelson AD, Frelinger AL 3rd, Braunwald E et al (2009) Pharmacodynamic assessment of platelet inhibition by prasugrel vs. clopidogrel in the TRITON-TIMI 38 trial. Eur Heart J 30:1753–1763
10. Storey RF, Angiolillo DJ, Patil SB et al (2010) Inhibitory effects of ticagrelor compared with clopidogrel on platelet function in patients with acute coronary syndromes: the PLATO (PLATelet inhibition and patient Outcomes) PLATELET substudy. J Am Coll Cardiol 56:1456–1462
11. Perl L, Lerman-Shivek H, Rechavia E et al (2014) Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 63(6):513–517
12. Alexopoulos D, Xanthopoulou I, Siapika A et al (2013) Evolving pattern of on-prasugrel and on-ticagrelor platelet reactivity over time in ST elevation myocardial infarction patients. Int J Cardiol 168(1):629–630
13. Gurbel PA, Bliden KP, Butler K et al (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 120:2577–2585
14. Robinson MS, Mackie IJ, Khair K et al (1998) Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br J Haematol 100:351–357
15. Lakkis N, Dokainish H, Abuzahra M et al (2004) Reticulated platelets in acute coronary syndrome: a marker of platelet activity. J Am Coll Cardiol 44:2091–2093
16. McCabe DJ, Harrison P, Sidhu PS, Brown MM, Machin SJ (2004) Circulating reticulated platelets in the early and late phases after ischaemic stroke and transient ischaemic attack. Br J Haematol 126:861–869
17. Guthikonda S, Alviar CL, Vaduganathan M et al (2008) Role of reticulated platelets and platelet size heterogeneity on platelet activity after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease. J Am Coll Cardiol 52:743–749
18. Kienast J, Schmitz G (1990) Flow cytometric analysis of thiazole orange uptake by platelets: a diagnostic aid in the evaluation of thrombocytopenic disorders. Blood 75:116–121
19. Harrison P, Goodall AH (2008) “Message in the platelet”—more than just vestigial Mrna. Platelets 19:395–404
20. Harrison P, Robinson MS, Mackie IJ, Machin SJ (1997) Reticulated platelets. Platelets 8:379–383
21. Guthikonda S, Lev EI, Patel R et al (2007) Reticulated platelets and uninhibited COX-1 and COX-2 decrease the antiplatelet effects of aspirin. J Thromb Haemost 5:490–496
22. Cesari F, Marcucci R, Gori AM et al (2013) Reticulated platelets predict cardiovascular death in acute coronary syndrome patients. Insights from the AMI- florence 2 study. Thromb Haemost 109:846–853